Display options
Cite
Ogino S, King EE, Beck AH, et al. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol. 2012;176(8):659-67doi: 10.1093/aje/kws226.
Ogino, S., King, E. E., Beck, A. H., Sherman, M. E., Milner, D. A., & Giovannucci, E. (2012). Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. American journal of epidemiology, 176(8), 659-67. https://doi.org/10.1093/aje/kws226
Ogino, Shuji, et al. "Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science." American journal of epidemiology vol. 176,8 (2012): 659-67. doi: https://doi.org/10.1093/aje/kws226
Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol. 2012 Oct 15;176(8):659-67. doi: 10.1093/aje/kws226. Epub 2012 Aug 30. PMID: 22935517; PMCID: PMC3571252.
Copy Download .nbib Format: NLM
Share it on

Am J Epidemiol. 2012 Oct 15;176(8):659-67. doi: 10.1093/aje/kws226. Epub 2012 Aug 30.

Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.

American journal of epidemiology

Shuji Ogino, Emily E King, Andrew H Beck, Mark E Sherman, Danny A Milner, Edward Giovannucci

Affiliations

  1. Cancer Epidemiology Program, Dana-Farber/Harvard Cancer Center, 450 Brookline Ave., Room JF-215C, Boston, MA 02215, USA. [email protected]

PMID: 22935517 PMCID: PMC3571252 DOI: 10.1093/aje/kws226

Abstract

In recent decades, epidemiology, public health, and medical sciences have been increasingly compartmentalized into narrower disciplines. The authors recognize the value of integration of divergent scientific fields in order to create new methods, concepts, paradigms, and knowledge. Herein they describe the recent emergence of molecular pathological epidemiology (MPE), which represents an integration of population and molecular biologic science to gain insights into the etiologies, pathogenesis, evolution, and outcomes of complex multifactorial diseases. Most human diseases, including common cancers (such as breast, lung, prostate, and colorectal cancers, leukemia, and lymphoma) and other chronic diseases (such as diabetes mellitus, cardiovascular diseases, hypertension, autoimmune diseases, psychiatric diseases, and some infectious diseases), are caused by alterations in the genome, epigenome, transcriptome, proteome, metabolome, microbiome, and interactome of all of the above components. In this era of personalized medicine and personalized prevention, we need integrated science (such as MPE) which can decipher diseases at the molecular, genetic, cellular, and population levels simultaneously. The authors believe that convergence and integration of multiple disciplines should be commonplace in research and education. We need to be open-minded and flexible in designing integrated education curricula and training programs for future students, clinicians, practitioners, and investigators.

References

  1. Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1149-50 - PubMed
  2. Int J Cancer. 2008 Nov 15;123(10):2456-9 - PubMed
  3. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1849-58 - PubMed
  4. J Mol Diagn. 2008 Jan;10(1):13-27 - PubMed
  5. Carcinogenesis. 2011 Jul;32(7):1043-9 - PubMed
  6. J Natl Cancer Inst. 2007 Mar 21;99(6):463-74 - PubMed
  7. J Natl Cancer Inst. 2010 Jul 21;102(14):1012-22 - PubMed
  8. Nat Med. 2012 Jan 22;18(2):224-6 - PubMed
  9. Am J Prev Med. 2008 Aug;35(2 Suppl):S77-89 - PubMed
  10. Cancer Prev Res (Phila). 2009 Sep;2(9):814-22 - PubMed
  11. Cancer Causes Control. 2006 Apr;17(3):229-37 - PubMed
  12. Int J Cancer. 2011 Aug 15;129(4):931-7 - PubMed
  13. Science. 2011 Jul 29;333(6042):527 - PubMed
  14. J Natl Cancer Inst. 2006 Dec 6;98(23):1731-8 - PubMed
  15. JAMA. 2006 Jul 12;296(2):212-5 - PubMed
  16. PLoS Med. 2005 Aug;2(8):e124 - PubMed
  17. PLoS Med. 2007 Oct 16;4(10):e296 - PubMed
  18. Gut. 2012 Jun;61(6):794-7 - PubMed
  19. J Natl Cancer Inst. 2012 Mar 7;104(5):415-20 - PubMed
  20. Am J Epidemiol. 2011 May 15;173(10):1183-91 - PubMed
  21. Neoplasia. 2009 Jan;11(1):87-95 - PubMed
  22. PLoS Med. 2011 Oct;8(10):e1001117 - PubMed
  23. Int J Cancer. 2007 Apr 15;120(8):1684-8 - PubMed
  24. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2513-21 - PubMed
  25. Biochim Biophys Acta. 2012 Jan;1825(1):77-85 - PubMed
  26. Cancer Invest. 2008 Jul;26(6):583-9 - PubMed
  27. N Engl J Med. 2007 May 24;356(21):2131-42 - PubMed
  28. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3086-96 - PubMed
  29. Nutr Cancer. 2011;63(3):357-66 - PubMed
  30. Gut. 2009 May;58(5):661-7 - PubMed
  31. Ann Surg Oncol. 2012 Aug;19(8):2726-32 - PubMed
  32. Am J Surg Pathol. 2012 Feb;36(2):202-13 - PubMed
  33. J Gastrointest Surg. 2005 Mar;9(3):329-35 - PubMed
  34. JAMA. 2011 Apr 13;305(14):1484-5 - PubMed
  35. J Natl Cancer Inst. 2010 Mar 17;102(6):391-400 - PubMed
  36. Int J Epidemiol. 2011 Jun;40(3):537-62 - PubMed
  37. Clin Cancer Res. 2009 Sep 15;15(18):5931-6 - PubMed
  38. Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2745-50 - PubMed
  39. Gut. 2010 Jun;59(6):794-9 - PubMed
  40. Anticancer Res. 2004 Mar-Apr;24(2B):649-54 - PubMed
  41. Cancer Prev Res (Phila). 2009 Oct;2(10):862-7 - PubMed
  42. Gut. 2011 Mar;60(3):397-411 - PubMed
  43. Cancers (Basel). 2011 Oct 14;3(4):3894-908 - PubMed
  44. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):429-36 - PubMed
  45. J Natl Cancer Inst. 2005 Jul 20;97(14):1023-5 - PubMed
  46. Lung Cancer. 2011 Feb;71(2):130-6 - PubMed
  47. Gut. 2012 Jun;61(6):847-54 - PubMed
  48. Carcinogenesis. 2001 Oct;22(10):1681-4 - PubMed
  49. Cancer Res. 2006 Jul 1;66(13):6877-83 - PubMed
  50. Am J Gastroenterol. 2009 Aug;104(8):2047-56 - PubMed
  51. Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):966-72 - PubMed
  52. Science. 2007 May 18;316(5827):1036-9 - PubMed
  53. Science. 2011 Aug 19;333(6045):919 - PubMed
  54. Mod Pathol. 2009 Dec;22(12):1588-99 - PubMed
  55. Genes Chromosomes Cancer. 2008 Oct;47(10):835-44 - PubMed
  56. J Clin Pathol. 2000 Jan;53(1):16-8 - PubMed
  57. Cancer Causes Control. 2011 Dec;22(12):1647-58 - PubMed
  58. Int J Cancer. 1999 Mar 31;81(1):1-5 - PubMed
  59. Am J Epidemiol. 2005 May 1;161(9):806-15 - PubMed
  60. JAMA. 2011 Apr 27;305(16):1685-94 - PubMed
  61. J Clin Oncol. 2008 Dec 10;26(35):5713-20 - PubMed
  62. J Clin Oncol. 2012 Jan 1;30(1):42-52 - PubMed
  63. J Natl Cancer Inst. 2000 Nov 15;92(22):1831-6 - PubMed
  64. Tumour Biol. 2011 Aug;32(4):653-9 - PubMed
  65. Int J Cancer. 2007 Feb 1;120(3):656-63 - PubMed
  66. Patholog Res Int. 2011 Apr 12;2011:902674 - PubMed
  67. Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):838-43 - PubMed
  68. Int J Cancer. 2012 Sep 1;131(5):1169-78 - PubMed
  69. Carcinogenesis. 2007 Sep;28(9):1985-90 - PubMed
  70. PLoS One. 2010 Jan 19;5(1):e8777 - PubMed
  71. Cancer Causes Control. 2010 Mar;21(3):331-45 - PubMed
  72. Clin Cancer Res. 2011 Apr 1;17(7):2014-23 - PubMed
  73. Carcinogenesis. 2007 Aug;28(8):1672-9 - PubMed
  74. Clin Cancer Res. 2010 Mar 15;16(6):1884-93 - PubMed
  75. Cancer Causes Control. 2010 Apr;21(4):557-66 - PubMed
  76. JAMA. 2009 Aug 12;302(6):649-58 - PubMed
  77. Nat Rev Clin Oncol. 2011 Aug 09;8(12):711-9 - PubMed
  78. Tumour Biol. 2012 Apr;33(2):337-46 - PubMed
  79. Gastroenterology. 2009 Nov;137(5):1609-20.e1-3 - PubMed
  80. Int J Epidemiol. 2007 Oct;36(5):946-8 - PubMed
  81. J Natl Cancer Inst. 2010 Mar 17;102(6):365-7 - PubMed
  82. Cell. 2010 Mar 19;140(6):883-99 - PubMed
  83. J Natl Compr Canc Netw. 2011 Nov;9(11):1293-302 - PubMed
  84. PLoS One. 2011 Apr 05;6(4):e18571 - PubMed
  85. Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):822-31 - PubMed
  86. PLoS Med. 2007 Oct 16;4(10):e297 - PubMed

MeSH terms

Publication Types

Grant support